SCHEMBL2604701

SCHEMBL2604701

COc1cccc(OBO)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.50
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
ENPP2 Q13822 1/20 0.48
CYP3A4 P08684 2/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
PARP1 P09874 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PRSS1 P07477 1/20 0.46
PRSS2 P07478 1/20 0.46
PRSS3 P35030 1/20 0.46
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,3-Dimethoxybenzene SCHEMBL2348353 0.86 ACHE (0.58) ACHECES2CES1ENPP2CYP3A4
SCHEMBL8402770 0.83 CYP1A2 (0.56) CYP3A4ALDH1A1LMNANPC1RAB9A
SCHEMBL30238353 0.82 ACHE (0.54) ACHECES2CES1ENPP2CYP3A4
SCHEMBL22274 0.82 ACHE (0.54) ACHECES2CES1ENPP2CYP3A4
SCHEMBL16303509 0.81 ALDH1A1 (0.58) CYP3A4CA1CA2ALDH1A1NPC1
SCHEMBL20413238 0.81 ABL1 (0.56) CYP3A4MAOBCYP1A1CYP1A2CYP2E1
1,3-Dimethoxybenzene SCHEMBL27700724 0.81 ACHE (0.64) ACHECES2CES1ENPP2CYP3A4
1,3-Dimethoxybenzene SCHEMBL901285 0.81 ACHE (0.70) ACHECES2CES1ENPP2CYP3A4
1,3-Dimethoxybenzene SCHEMBL9350 0.81 ACHE (0.70) ACHECES2CES1ENPP2CYP3A4
SCHEMBL11885381 0.78 ACHE (0.56) ACHEALDH1A1LMNAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113004194-B Circular polarization luminescent organic micro-nano crystal material and preparation method and application thereof 中国科学院化学研究所 2022-12-09 CN claimed
US-12024536-B2 C-terminal HSP90 inhibitors UNIVERSITY OF KANSAS (US) 2024-07-02 US disclosed
US-20240018103-A1 3-HYDROXYOXINDOLE DERIVATIVES AS CRHR2 ANTAGONIST RAQUALIA PHARMA INC. (JP) 2024-01-18 US disclosed
CN-114656397-B Compound, two-dimensional organic crystal containing compound, preparation method and application 中国科学院化学研究所 2023-07-25 CN disclosed
CN-113004194-B Circular polarization luminescent organic micro-nano crystal material and preparation method and application thereof 中国科学院化学研究所 2022-12-09 CN disclosed
CN-113004194-A Circular polarization luminescent organic micro-nano crystal material and preparation method and application thereof 中国科学院化学研究所 2021-06-22 CN disclosed
US-20180212158-A1 ORGANIC LIGHT-EMITTING DIODE MATERIALS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2018-07-26 US disclosed
US-10030041-B2 C-terminal Hsp90 inhibitors UNIVERSITY OF KANSAS (US) 2018-07-24 US disclosed
US-9997712-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2018-06-12 US disclosed
US-20180118707-A1 BETA-NAPHTHOISOFLAVONES, COMPOSITIONS CONTAINING, AND USES OF, SAME THESAN PHARMACEUTICALS, INC. (US) 2018-05-03 US disclosed
US-20130012434-A1 NOVEL SPIRO IMIDAZOLONES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE MERCK SHARP & DOHME CORP. 2013-01-10 US disclosed
US-20130001538-A1 Triphenylene Hosts in Phosphorescent Light Emitting Diodes UNIVERSAL DISPLAY CORPORATION (US) 2013-01-03 US disclosed
US-8283360-B2 Bicyclic heterocyclic derivatives and methods of use thereof MERCK SHARP & DOHME CORP. (US) 2012-10-09 US disclosed
US-20120129852-A1 AZAINDAZOLES AS KINASE INHIBITORS AND USE THEREOF BRISTOL-MYERS SQUIBB COMPANY 2012-05-24 US disclosed
US-20120092608-A1 POLYMERIZABLE COMPOUND AND LIQUID CRYSTAL COMPOSITION INCLUDING IT JNC PETROCHEMICAL CORPORATION (JP) 2012-04-19 US disclosed
US-20120032156-A1 Triphenylene Hosts in Phosphorescent Light Emitting Diodes UNIVERSAL DISPLAY CORPORATION 2012-02-09 US disclosed
US-20110319434-A1 Bicyclic Heterocyclic Derivatives and Methods of Use Thereof SCHERING PLOUGH CORPORATION (US) 2011-12-29 US disclosed
US-20110108814-A1 POLYMER COMPOUND, NET-LIKE POLYMER COMPOUND PRODUCED BY CROSSLINKING THE POLYMER COMPOUND, COMPOSITION FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC EL DISPLAY, AND ORGANIC EL LIGHTING MITSUBISHI CHEMICAL CORPORATION (JP) 2011-05-12 US disclosed
US-20110105457-A1 HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON PI3K SHIONOGI & CO., LTD. 2011-05-05 US disclosed
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021771-A1 INHIBITORS OF HISTONE DEACETYLASE HDAC1, HDAC11, HDAC3 ACHE 1157/4885CES2 998/4885CES1 477/4885
US-20240018103-A1 3-HYDROXYOXINDOLE DERIVATIVES AS CRHR2 ANTAGONIST CRHR2, CRHR1, CRH ACHE 4652/4885CES2 2186/4885CES1 1763/4885
US-20120129852-A1 AZAINDAZOLES AS KINASE INHIBITORS AND USE THEREOF BTK, ABL1, JAK1 ACHE 2890/4885CES2 2687/4885CES1 1630/4885
US-20180212158-A1 ORGANIC LIGHT-EMITTING DIODE MATERIALS MSN, DDT, NECTIN4 ACHE 1237/4885CES2 2529/4885CES1 3777/4885
US-20110319434-A1 Bicyclic Heterocyclic Derivatives and Methods of Use Thereof GPR119, GID4, TLR4 ACHE 501/4885CES2 460/4885CES1 336/4885
US-20180118707-A1 BETA-NAPHTHOISOFLAVONES, COMPOSITIONS CONTAINING, AND USES OF, SAME AHR, ARNT, NR1H2 ACHE 2933/4885CES2 904/4885CES1 232/4885
US-20110105457-A1 HETEROCYCLIC COMPOUND HAVING INHIBITORY ACTIVITY ON PI3K MTOR, STAT3, PIK3CD ACHE 4163/4885CES2 3647/4885CES1 2936/4885
US-20130012434-A1 NOVEL SPIRO IMIDAZOLONES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE GLP1R, GCGR, GIPR ACHE 4453/4885CES2 3753/4885CES1 723/4885
US-10030041-B2 C-terminal Hsp90 inhibitors HSP90AB2P, HSP90AB1, HSP90B1 ACHE 4281/4885CES2 3641/4885CES1 3799/4885
US-12024536-B2 C-terminal HSP90 inhibitors HSP90AB2P, HSP90AB1, HSP90B1 ACHE 4281/4885CES2 3641/4885CES1 3799/4885
US-20120092608-A1 POLYMERIZABLE COMPOUND AND LIQUID CRYSTAL COMPOSITION INCLUDING IT KLK3, PDE7A, FZD7 ACHE 3013/4885CES2 4100/4885CES1 4615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.